The manufacturing of the drug will be retained by TJ Biopharma at its site in Hangzhou, which would make felzartamab China’s ...
The EMA’s CHMP has stated its positive opinions on three drugs for autoimmune, muscle wasting and rare genetic diseases.
Biogen heads into Q1 earnings with new drugs like Skyclarys and Zurzuvae driving growth as legacy MS products face rising competitive pressure.
Recognizing the signs of mild cognitive impairment meant Di could start treatment earlier to help slow her Alzheimer's ...
North Longford woman Kiara Lynch recently met with local TD Micheál Carrigy to discuss her campaign calling on the HSE to ...
MedPage Today on MSN
Real-world registry study shows Alzheimer's drug safety outcomes
No new signals for lecanemab emerged in ALZ-NET ...
MedPage Today on MSN
Cell therapy slows upper limb decline in Duchenne muscular dystrophy
Investigational deramiocel is back under FDA review again ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results